Cone (rod) dystrophy: identification of the molecular defects and clinical consequences

Cone (rod) dystrophy: identification of the molecular defects and clinical consequences - Cone (rod) dystrophies: genotype and phenotype

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31001

Enrollment

350

Registered

2007-10-30

Start date

2007-11-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(juvenile) macula degeneration of macular/cone dysfunction

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: > 50 years normal visual acuity normal color vision normal ERG responses no central scotoma

Design outcomes

Primary

Measure	Time frame
Primary study parameters These are genetic mutations and haplotypes. Primary outcome of the study CORD.	—

Secondary

Measure	Time frame
Secundary study parameters Age, sexe, tabacco intake, UV-exposition, intake of anti-oxidants and omega-3-lipids (DHA en EPA), vascular co-morbidity Secundary outcome Visual acuity, age of onset, quantification of color vision defects, photopic ERG responses, bull's eye maculopathy	—

Countries

Netherlands

Outcome results